10x Genomics | Pleasanton, CA &amp; San Francisco, CA | Software Engineers, multiple levels
Track cancer, not ads.
If you're a software engineer looking to make a positive impact on human health without compromising on cutting-edge technology or career benefits, consider applying to 10x Genomics.
10x Genomics is a fast-growing biotech company that develops hardware, software, and chemistry that enables researchers to study cancer, the immune system, and biology at an unprecedented resolution. Researchers at 93 of the top 100 global research institutions and 13 of the top 15 global pharmaceutical companies use our technology to make groundbreaking discoveries in diseases like cancer, Alzheimer's, cystic fibrosis, asthma, and many more. We went public last month and it was the largest healthcare IPO of 2019.
Software is at the heart of the 10x Genomics platform. We develop software to convert petabytes of raw sequencing data to something scientists can explore programmatically or visually. We have developed internal and customer-shipping systems in Go, use React/Redux, Typescript, and Electron for easy-to-use visualization applications, and are making increasing use of Rust to accelerate and harden our bioinformatics code.
There are open positions for front-end software engineers (remote-friendly), full stack engineers, backend engineers, QA engineers, site reliability engineers, computational biologists, and firmware engineers. See <a href=" or email me (REDACTED_EMAIL) directly.
We're offering:
  - Competitive salary with options
  - Work with domain experts across a variety of fields
  - Medical, dental, vision, FSA, 401(k), ESPP, and other benefits
  - Unlimited vacation policy
  - A beautiful new HQ within walking distance of West Dublin/Pleasanton BART
  - A satellite office in downtown SF
  - Eat Club (at HQ) 3 days a week, unlimited snacks
  - The existential satisfaction of knowing your software is being used to study and improve human health

We look forward to hearing from you!
Ask HN: Who is hiring? (October 2019)